Investment
Features
FeesSafety
Academy
More
Pluang+

Compare The Magnum Ice Cream Company N.V. Ordinary Shares (MICC) vs Natera Inc. Common Stock (NTRA) Price & Performance

The Magnum Ice Cream Company N.V. Ordinary SharesTrade
Natera Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

The Magnum Ice Cream Company N.V. Ordinary Shares vs Natera Inc. Common Stock — how do they compare? The Magnum Ice Cream Company N.V. Ordinary Shares trades at $18.49 (market cap $10.72B), while Natera Inc. Common Stock trades at $393.27 (market cap $57.03B). The key difference: Natera Inc. Common Stock is far larger — about 5.3× The Magnum Ice Cream Company N.V. Ordinary Shares's market cap, and Natera Inc. Common Stock is trading nearer its 52-week high, The Magnum Ice Cream Company N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold The Magnum Ice Cream Company N.V. Ordinary Shares for 0 Days and Natera Inc. Common Stock for 0 Days on average.

MICCNTRA
Market Cap
$10.72B$57.03B
Volume
1,309,6501,131,157
Sector
Consumer StaplesHealth
52-Week High
$20.42$425.64
52-Week Low
$13.06$179.42
Typical Hold Time
0 Days0 Days
Enterprise Value
$14.14B$56.18B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

The Magnum Ice Cream Company N.V. Ordinary Shares

No Aura AI signal available yet.

Natera Inc. Common Stock

NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.

NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MICC
100% Buy0% Sell
Avg holding period · 0 Days
NTRA
100% Buy0% Sell
Avg holding period · 0 Days

About The Magnum Ice Cream Company N.V. Ordinary Shares

The Magnum Ice Cream Company N.V. manufactures and sells ice cream and frozen desserts through brands including Magnum, Ben & Jerry's, Wall's, and Cornetto, distributing across roughly 80 countries.

Read more on MICC →

About Natera Inc. Common Stock

Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.

Read more on NTRA →